Impax Denied Parkinson's Drug Approval Over Plant Issues
The U.S. Food and Drug and Administration on Monday refused to approve Impax Laboratories Inc.'s proposed Parkinson's disease treatment Rytary, saying it needed evidence the company had improved testing conditions at...To view the full article, register now.
Already a subscriber? Click here to view full article